SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 37 filers reported holding SQZ BIOTECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 350 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -75.0% | 350 | -30.0% | 0.00% | -100.0% |
| Q4 2021 | $4,000 | -42.9% | 500 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $7,000 | 0.0% | 500 | -7.1% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | -12.5% | 538 | -10.3% | 0.00% | -33.3% |
| Q1 2021 | $8,000 | -20.0% | 600 | +71.4% | 0.00% | 0.0% |
| Q4 2020 | $10,000 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 807,827 | $23,411,000 | 1.79% |
| Alphabet Inc. | 831,389 | $24,094,000 | 1.16% |
| Artal Group S.A. | 1,606,308 | $46,551,000 | 1.00% |
| 683 Capital Management, LLC | 466,176 | $13,510,000 | 0.64% |
| MAVERICK CAPITAL LTD | 935,971 | $27,124,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 2,513,924 | $72,854,000 | 0.31% |
| CAAS CAPITAL MANAGEMENT LP | 150,000 | $4,347,000 | 0.04% |
| HRT FINANCIAL LP | 17,456 | $505,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 11,660 | $350,000 | 0.01% |
| Hudock, Inc. | 350 | $10,000 | 0.00% |